- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Fibromyalgia Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Fibromyalgia Treatment market size is estimated to be worth US$ 2945.2 million in 2021 and is forecast to a readjusted size of USD 3308.4 million by 2028 with a CAGR of 1.7% during review period. Hospitals Pharmacies accounting for % of the Fibromyalgia Treatment global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Antidepressants segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Fibromyalgia Treatment include Eli Lilly and Company, Pfizer, Novartis AG, Allergan, and Aptinyx, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Fibromyalgia Treatment market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Antidepressants
Anticonvulsants
Muscle Relaxants
Narcotic Analgesics
Non-narcotic Analgesics
Market segment by Application can be divided into
Hospitals Pharmacies
Clinic Pharmacy
Retail Drug Stores
Online Pharmacies
The key market players for global Fibromyalgia Treatment market are listed below:
Eli Lilly and Company
Pfizer
Novartis AG
Allergan
Aptinyx
Prismic Pharmaceuticals
Innovative Med Concepts
Intec Pharma Ltd.
Astellas Pharma
Savella
Sun Pharmaceutical Industries
Mylan NV
Teva Pharmaceutical Industries
Daiichi Sankyo
Forest Pharmaceuticals
Meiji Seika Pharma
Tonix Pharmaceuticals
Theravance Biopharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Fibromyalgia Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Fibromyalgia Treatment, with price, sales, revenue and global market share of Fibromyalgia Treatment from 2019 to 2022.
Chapter 3, the Fibromyalgia Treatment competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Fibromyalgia Treatment breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Fibromyalgia Treatment market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Fibromyalgia Treatment.
Chapter 13, 14, and 15, to describe Fibromyalgia Treatment sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Fibromyalgia Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Fibromyalgia Treatment Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Antidepressants
1.2.3 Anticonvulsants
1.2.4 Muscle Relaxants
1.2.5 Narcotic Analgesics
1.2.6 Non-narcotic Analgesics
1.3 Market Analysis by Application
1.3.1 Overview: Global Fibromyalgia Treatment Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals Pharmacies
1.3.3 Clinic Pharmacy
1.3.4 Retail Drug Stores
1.3.5 Online Pharmacies
1.4 Global Fibromyalgia Treatment Market Size & Forecast
1.4.1 Global Fibromyalgia Treatment Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Fibromyalgia Treatment Sales in Volume (2017-2028)
1.4.3 Global Fibromyalgia Treatment Price (2017-2028)
1.5 Global Fibromyalgia Treatment Production Capacity Analysis
1.5.1 Global Fibromyalgia Treatment Total Production Capacity (2017-2028)
1.5.2 Global Fibromyalgia Treatment Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Fibromyalgia Treatment Market Drivers
1.6.2 Fibromyalgia Treatment Market Restraints
1.6.3 Fibromyalgia Treatment Trends Analysis
2 Manufacturers Profiles
2.1 Eli Lilly and Company
2.1.1 Eli Lilly and Company Details
2.1.2 Eli Lilly and Company Major Business
2.1.3 Eli Lilly and Company Fibromyalgia Treatment Product and Services
2.1.4 Eli Lilly and Company Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Fibromyalgia Treatment Product and Services
2.2.4 Pfizer Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Novartis AG
2.3.1 Novartis AG Details
2.3.2 Novartis AG Major Business
2.3.3 Novartis AG Fibromyalgia Treatment Product and Services
2.3.4 Novartis AG Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Allergan
2.4.1 Allergan Details
2.4.2 Allergan Major Business
2.4.3 Allergan Fibromyalgia Treatment Product and Services
2.4.4 Allergan Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Aptinyx
2.5.1 Aptinyx Details
2.5.2 Aptinyx Major Business
2.5.3 Aptinyx Fibromyalgia Treatment Product and Services
2.5.4 Aptinyx Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Prismic Pharmaceuticals
2.6.1 Prismic Pharmaceuticals Details
2.6.2 Prismic Pharmaceuticals Major Business
2.6.3 Prismic Pharmaceuticals Fibromyalgia Treatment Product and Services
2.6.4 Prismic Pharmaceuticals Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Innovative Med Concepts
2.7.1 Innovative Med Concepts Details
2.7.2 Innovative Med Concepts Major Business
2.7.3 Innovative Med Concepts Fibromyalgia Treatment Product and Services
2.7.4 Innovative Med Concepts Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Intec Pharma Ltd.
2.8.1 Intec Pharma Ltd. Details
2.8.2 Intec Pharma Ltd. Major Business
2.8.3 Intec Pharma Ltd. Fibromyalgia Treatment Product and Services
2.8.4 Intec Pharma Ltd. Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Astellas Pharma
2.9.1 Astellas Pharma Details
2.9.2 Astellas Pharma Major Business
2.9.3 Astellas Pharma Fibromyalgia Treatment Product and Services
2.9.4 Astellas Pharma Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Savella
2.10.1 Savella Details
2.10.2 Savella Major Business
2.10.3 Savella Fibromyalgia Treatment Product and Services
2.10.4 Savella Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Sun Pharmaceutical Industries
2.11.1 Sun Pharmaceutical Industries Details
2.11.2 Sun Pharmaceutical Industries Major Business
2.11.3 Sun Pharmaceutical Industries Fibromyalgia Treatment Product and Services
2.11.4 Sun Pharmaceutical Industries Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Mylan NV
2.12.1 Mylan NV Details
2.12.2 Mylan NV Major Business
2.12.3 Mylan NV Fibromyalgia Treatment Product and Services
2.12.4 Mylan NV Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Teva Pharmaceutical Industries
2.13.1 Teva Pharmaceutical Industries Details
2.13.2 Teva Pharmaceutical Industries Major Business
2.13.3 Teva Pharmaceutical Industries Fibromyalgia Treatment Product and Services
2.13.4 Teva Pharmaceutical Industries Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Daiichi Sankyo
2.14.1 Daiichi Sankyo Details
2.14.2 Daiichi Sankyo Major Business
2.14.3 Daiichi Sankyo Fibromyalgia Treatment Product and Services
2.14.4 Daiichi Sankyo Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Forest Pharmaceuticals
2.15.1 Forest Pharmaceuticals Details
2.15.2 Forest Pharmaceuticals Major Business
2.15.3 Forest Pharmaceuticals Fibromyalgia Treatment Product and Services
2.15.4 Forest Pharmaceuticals Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Meiji Seika Pharma
2.16.1 Meiji Seika Pharma Details
2.16.2 Meiji Seika Pharma Major Business
2.16.3 Meiji Seika Pharma Fibromyalgia Treatment Product and Services
2.16.4 Meiji Seika Pharma Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Tonix Pharmaceuticals
2.17.1 Tonix Pharmaceuticals Details
2.17.2 Tonix Pharmaceuticals Major Business
2.17.3 Tonix Pharmaceuticals Fibromyalgia Treatment Product and Services
2.17.4 Tonix Pharmaceuticals Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Theravance Biopharma
2.18.1 Theravance Biopharma Details
2.18.2 Theravance Biopharma Major Business
2.18.3 Theravance Biopharma Fibromyalgia Treatment Product and Services
2.18.4 Theravance Biopharma Fibromyalgia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Fibromyalgia Treatment Breakdown Data by Manufacturer
3.1 Global Fibromyalgia Treatment Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Fibromyalgia Treatment Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Fibromyalgia Treatment
3.4 Market Concentration Rate
3.4.1 Top 3 Fibromyalgia Treatment Manufacturer Market Share in 2021
3.4.2 Top 6 Fibromyalgia Treatment Manufacturer Market Share in 2021
3.5 Global Fibromyalgia Treatment Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Fibromyalgia Treatment Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Fibromyalgia Treatment Market Size by Region
4.1.1 Global Fibromyalgia Treatment Sales in Volume by Region (2017-2028)
4.1.2 Global Fibromyalgia Treatment Revenue by Region (2017-2028)
4.2 North America Fibromyalgia Treatment Revenue (2017-2028)
4.3 Europe Fibromyalgia Treatment Revenue (2017-2028)
4.4 Asia-Pacific Fibromyalgia Treatment Revenue (2017-2028)
4.5 South America Fibromyalgia Treatment Revenue (2017-2028)
4.6 Middle East and Africa Fibromyalgia Treatment Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Fibromyalgia Treatment Sales in Volume by Type (2017-2028)
5.2 Global Fibromyalgia Treatment Revenue by Type (2017-2028)
5.3 Global Fibromyalgia Treatment Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Fibromyalgia Treatment Sales in Volume by Application (2017-2028)
6.2 Global Fibromyalgia Treatment Revenue by Application (2017-2028)
6.3 Global Fibromyalgia Treatment Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Fibromyalgia Treatment Sales by Type (2017-2028)
7.2 North America Fibromyalgia Treatment Sales by Application (2017-2028)
7.3 North America Fibromyalgia Treatment Market Size by Country
7.3.1 North America Fibromyalgia Treatment Sales in Volume by Country (2017-2028)
7.3.2 North America Fibromyalgia Treatment Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Fibromyalgia Treatment Sales by Type (2017-2028)
8.2 Europe Fibromyalgia Treatment Sales by Application (2017-2028)
8.3 Europe Fibromyalgia Treatment Market Size by Country
8.3.1 Europe Fibromyalgia Treatment Sales in Volume by Country (2017-2028)
8.3.2 Europe Fibromyalgia Treatment Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Fibromyalgia Treatment Sales by Type (2017-2028)
9.2 Asia-Pacific Fibromyalgia Treatment Sales by Application (2017-2028)
9.3 Asia-Pacific Fibromyalgia Treatment Market Size by Region
9.3.1 Asia-Pacific Fibromyalgia Treatment Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Fibromyalgia Treatment Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Fibromyalgia Treatment Sales by Type (2017-2028)
10.2 South America Fibromyalgia Treatment Sales by Application (2017-2028)
10.3 South America Fibromyalgia Treatment Market Size by Country
10.3.1 South America Fibromyalgia Treatment Sales in Volume by Country (2017-2028)
10.3.2 South America Fibromyalgia Treatment Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Fibromyalgia Treatment Sales by Type (2017-2028)
11.2 Middle East & Africa Fibromyalgia Treatment Sales by Application (2017-2028)
11.3 Middle East & Africa Fibromyalgia Treatment Market Size by Country
11.3.1 Middle East & Africa Fibromyalgia Treatment Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Fibromyalgia Treatment Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Fibromyalgia Treatment and Key Manufacturers
12.2 Manufacturing Costs Percentage of Fibromyalgia Treatment
12.3 Fibromyalgia Treatment Production Process
12.4 Fibromyalgia Treatment Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Fibromyalgia Treatment Typical Distributors
13.3 Fibromyalgia Treatment Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Fibromyalgia Treatment Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Fibromyalgia Treatment Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 4. Eli Lilly and Company Major Business
Table 5. Eli Lilly and Company Fibromyalgia Treatment Product and Services
Table 6. Eli Lilly and Company Fibromyalgia Treatment Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Fibromyalgia Treatment Product and Services
Table 10. Pfizer Fibromyalgia Treatment Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 12. Novartis AG Major Business
Table 13. Novartis AG Fibromyalgia Treatment Product and Services
Table 14. Novartis AG Fibromyalgia Treatment Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Allergan Basic Information, Manufacturing Base and Competitors
Table 16. Allergan Major Business
Table 17. Allergan Fibromyalgia Treatment Product and Services
Table 18. Allergan Fibromyalgia Treatment Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Aptinyx Basic Information, Manufacturing Base and Competitors
Table 20. Aptinyx Major Business
Table 21. Aptinyx Fibromyalgia Treatment Product and Services
Table 22. Aptinyx Fibromyalgia Treatment Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Prismic Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Prismic Pharmaceuticals Major Business
Table 25. Prismic Pharmaceuticals Fibromyalgia Treatment Product and Services
Table 26. Prismic Pharmaceuticals Fibromyalgia Treatment Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Innovative Med Concepts Basic Information, Manufacturing Base and Competitors
Table 28. Innovative Med Concepts Major Business
Table 29. Innovative Med Concepts Fibromyalgia Treatment Product and Services
Table 30. Innovative Med Concepts Fibromyalgia Treatment Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Intec Pharma Ltd. Basic Information, Manufacturing Base and Competitors
Table 32. Intec Pharma Ltd. Major Business
Table 33. Intec Pharma Ltd. Fibromyalgia Treatment Product and Services
Table 34. Intec Pharma Ltd. Fibromyalgia Treatment Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 36. Astellas Pharma Major Business
Table 37. Astellas Pharma Fibromyalgia Treatment Product and Services
Table 38. Astellas Pharma Fibromyalgia Treatment Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Savella Basic Information, Manufacturing Base and Competitors
Table 40. Savella Major Business
Table 41. Savella Fibromyalgia Treatment Product and Services
Table 42. Savella Fibromyalgia Treatment Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 44. Sun Pharmaceutical Industries Major Business
Table 45. Sun Pharmaceutical Industries Fibromyalgia Treatment Product and Services
Table 46. Sun Pharmaceutical Industries Fibromyalgia Treatment Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Mylan NV Basic Information, Manufacturing Base and Competitors
Table 48. Mylan NV Major Business
Table 49. Mylan NV Fibromyalgia Treatment Product and Services
Table 50. Mylan NV Fibromyalgia Treatment Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 52. Teva Pharmaceutical Industries Major Business
Table 53. Teva Pharmaceutical Industries Fibromyalgia Treatment Product and Services
Table 54. Teva Pharmaceutical Industries Fibromyalgia Treatment Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 56. Daiichi Sankyo Major Business
Table 57. Daiichi Sankyo Fibromyalgia Treatment Product and Services
Table 58. Daiichi Sankyo Fibromyalgia Treatment Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Forest Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 60. Forest Pharmaceuticals Major Business
Table 61. Forest Pharmaceuticals Fibromyalgia Treatment Product and Services
Table 62. Forest Pharmaceuticals Fibromyalgia Treatment Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Meiji Seika Pharma Basic Information, Manufacturing Base and Competitors
Table 64. Meiji Seika Pharma Major Business
Table 65. Meiji Seika Pharma Fibromyalgia Treatment Product and Services
Table 66. Meiji Seika Pharma Fibromyalgia Treatment Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Tonix Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. Tonix Pharmaceuticals Major Business
Table 69. Tonix Pharmaceuticals Fibromyalgia Treatment Product and Services
Table 70. Tonix Pharmaceuticals Fibromyalgia Treatment Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Theravance Biopharma Basic Information, Manufacturing Base and Competitors
Table 72. Theravance Biopharma Major Business
Table 73. Theravance Biopharma Fibromyalgia Treatment Product and Services
Table 74. Theravance Biopharma Fibromyalgia Treatment Sales (KG), Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Global Fibromyalgia Treatment Sales by Manufacturer (2019, 2020, 2021, and 2022) & (KG)
Table 76. Global Fibromyalgia Treatment Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 77. Market Position of Manufacturers in Fibromyalgia Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 78. Global Fibromyalgia Treatment Production Capacity by Company, (KG): 2020 VS 2021
Table 79. Head Office and Fibromyalgia Treatment Production Site of Key Manufacturer
Table 80. Fibromyalgia Treatment New Entrant and Capacity Expansion Plans
Table 81. Fibromyalgia Treatment Mergers & Acquisitions in the Past Five Years
Table 82. Global Fibromyalgia Treatment Sales by Region (2017-2022) & (KG)
Table 83. Global Fibromyalgia Treatment Sales by Region (2023-2028) & (KG)
Table 84. Global Fibromyalgia Treatment Revenue by Region (2017-2022) & (USD Million)
Table 85. Global Fibromyalgia Treatment Revenue by Region (2023-2028) & (USD Million)
Table 86. Global Fibromyalgia Treatment Sales by Type (2017-2022) & (KG)
Table 87. Global Fibromyalgia Treatment Sales by Type (2023-2028) & (KG)
Table 88. Global Fibromyalgia Treatment Revenue by Type (2017-2022) & (USD Million)
Table 89. Global Fibromyalgia Treatment Revenue by Type (2023-2028) & (USD Million)
Table 90. Global Fibromyalgia Treatment Price by Type (2017-2022) & (USD/KG)
Table 91. Global Fibromyalgia Treatment Price by Type (2023-2028) & (USD/KG)
Table 92. Global Fibromyalgia Treatment Sales by Application (2017-2022) & (KG)
Table 93. Global Fibromyalgia Treatment Sales by Application (2023-2028) & (KG)
Table 94. Global Fibromyalgia Treatment Revenue by Application (2017-2022) & (USD Million)
Table 95. Global Fibromyalgia Treatment Revenue by Application (2023-2028) & (USD Million)
Table 96. Global Fibromyalgia Treatment Price by Application (2017-2022) & (USD/KG)
Table 97. Global Fibromyalgia Treatment Price by Application (2023-2028) & (USD/KG)
Table 98. North America Fibromyalgia Treatment Sales by Country (2017-2022) & (KG)
Table 99. North America Fibromyalgia Treatment Sales by Country (2023-2028) & (KG)
Table 100. North America Fibromyalgia Treatment Revenue by Country (2017-2022) & (USD Million)
Table 101. North America Fibromyalgia Treatment Revenue by Country (2023-2028) & (USD Million)
Table 102. North America Fibromyalgia Treatment Sales by Type (2017-2022) & (KG)
Table 103. North America Fibromyalgia Treatment Sales by Type (2023-2028) & (KG)
Table 104. North America Fibromyalgia Treatment Sales by Application (2017-2022) & (KG)
Table 105. North America Fibromyalgia Treatment Sales by Application (2023-2028) & (KG)
Table 106. Europe Fibromyalgia Treatment Sales by Country (2017-2022) & (KG)
Table 107. Europe Fibromyalgia Treatment Sales by Country (2023-2028) & (KG)
Table 108. Europe Fibromyalgia Treatment Revenue by Country (2017-2022) & (USD Million)
Table 109. Europe Fibromyalgia Treatment Revenue by Country (2023-2028) & (USD Million)
Table 110. Europe Fibromyalgia Treatment Sales by Type (2017-2022) & (KG)
Table 111. Europe Fibromyalgia Treatment Sales by Type (2023-2028) & (KG)
Table 112. Europe Fibromyalgia Treatment Sales by Application (2017-2022) & (KG)
Table 113. Europe Fibromyalgia Treatment Sales by Application (2023-2028) & (KG)
Table 114. Asia-Pacific Fibromyalgia Treatment Sales by Region (2017-2022) & (KG)
Table 115. Asia-Pacific Fibromyalgia Treatment Sales by Region (2023-2028) & (KG)
Table 116. Asia-Pacific Fibromyalgia Treatment Revenue by Region (2017-2022) & (USD Million)
Table 117. Asia-Pacific Fibromyalgia Treatment Revenue by Region (2023-2028) & (USD Million)
Table 118. Asia-Pacific Fibromyalgia Treatment Sales by Type (2017-2022) & (KG)
Table 119. Asia-Pacific Fibromyalgia Treatment Sales by Type (2023-2028) & (KG)
Table 120. Asia-Pacific Fibromyalgia Treatment Sales by Application (2017-2022) & (KG)
Table 121. Asia-Pacific Fibromyalgia Treatment Sales by Application (2023-2028) & (KG)
Table 122. South America Fibromyalgia Treatment Sales by Country (2017-2022) & (KG)
Table 123. South America Fibromyalgia Treatment Sales by Country (2023-2028) & (KG)
Table 124. South America Fibromyalgia Treatment Revenue by Country (2017-2022) & (USD Million)
Table 125. South America Fibromyalgia Treatment Revenue by Country (2023-2028) & (USD Million)
Table 126. South America Fibromyalgia Treatment Sales by Type (2017-2022) & (KG)
Table 127. South America Fibromyalgia Treatment Sales by Type (2023-2028) & (KG)
Table 128. South America Fibromyalgia Treatment Sales by Application (2017-2022) & (KG)
Table 129. South America Fibromyalgia Treatment Sales by Application (2023-2028) & (KG)
Table 130. Middle East & Africa Fibromyalgia Treatment Sales by Region (2017-2022) & (KG)
Table 131. Middle East & Africa Fibromyalgia Treatment Sales by Region (2023-2028) & (KG)
Table 132. Middle East & Africa Fibromyalgia Treatment Revenue by Region (2017-2022) & (USD Million)
Table 133. Middle East & Africa Fibromyalgia Treatment Revenue by Region (2023-2028) & (USD Million)
Table 134. Middle East & Africa Fibromyalgia Treatment Sales by Type (2017-2022) & (KG)
Table 135. Middle East & Africa Fibromyalgia Treatment Sales by Type (2023-2028) & (KG)
Table 136. Middle East & Africa Fibromyalgia Treatment Sales by Application (2017-2022) & (KG)
Table 137. Middle East & Africa Fibromyalgia Treatment Sales by Application (2023-2028) & (KG)
Table 138. Fibromyalgia Treatment Raw Material
Table 139. Key Manufacturers of Fibromyalgia Treatment Raw Materials
Table 140. Direct Channel Pros & Cons
Table 141. Indirect Channel Pros & Cons
Table 142. Fibromyalgia Treatment Typical Distributors
Table 143. Fibromyalgia Treatment Typical Customers
List of Figures
Figure 1. Fibromyalgia Treatment Picture
Figure 2. Global Fibromyalgia Treatment Revenue Market Share by Type in 2021
Figure 3. Antidepressants
Figure 4. Anticonvulsants
Figure 5. Muscle Relaxants
Figure 6. Narcotic Analgesics
Figure 7. Non-narcotic Analgesics
Figure 8. Global Fibromyalgia Treatment Revenue Market Share by Application in 2021
Figure 9. Hospitals Pharmacies
Figure 10. Clinic Pharmacy
Figure 11. Retail Drug Stores
Figure 12. Online Pharmacies
Figure 13. Global Fibromyalgia Treatment Revenue, (USD Million) & (KG): 2017 & 2021 & 2028
Figure 14. Global Fibromyalgia Treatment Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Fibromyalgia Treatment Sales (2017-2028) & (KG)
Figure 16. Global Fibromyalgia Treatment Price (2017-2028) & (USD/KG)
Figure 17. Global Fibromyalgia Treatment Production Capacity (2017-2028) & (KG)
Figure 18. Global Fibromyalgia Treatment Production Capacity by Geographic Region: 2022 VS 2028
Figure 19. Fibromyalgia Treatment Market Drivers
Figure 20. Fibromyalgia Treatment Market Restraints
Figure 21. Fibromyalgia Treatment Market Trends
Figure 22. Global Fibromyalgia Treatment Sales Market Share by Manufacturer in 2021
Figure 23. Global Fibromyalgia Treatment Revenue Market Share by Manufacturer in 2021
Figure 24. Fibromyalgia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 25. Top 3 Fibromyalgia Treatment Manufacturer (Revenue) Market Share in 2021
Figure 26. Top 6 Fibromyalgia Treatment Manufacturer (Revenue) Market Share in 2021
Figure 27. Global Fibromyalgia Treatment Sales Market Share by Region (2017-2028)
Figure 28. Global Fibromyalgia Treatment Revenue Market Share by Region (2017-2028)
Figure 29. North America Fibromyalgia Treatment Revenue (2017-2028) & (USD Million)
Figure 30. Europe Fibromyalgia Treatment Revenue (2017-2028) & (USD Million)
Figure 31. Asia-Pacific Fibromyalgia Treatment Revenue (2017-2028) & (USD Million)
Figure 32. South America Fibromyalgia Treatment Revenue (2017-2028) & (USD Million)
Figure 33. Middle East & Africa Fibromyalgia Treatment Revenue (2017-2028) & (USD Million)
Figure 34. Global Fibromyalgia Treatment Sales Market Share by Type (2017-2028)
Figure 35. Global Fibromyalgia Treatment Revenue Market Share by Type (2017-2028)
Figure 36. Global Fibromyalgia Treatment Price by Type (2017-2028) & (USD/KG)
Figure 37. Global Fibromyalgia Treatment Sales Market Share by Application (2017-2028)
Figure 38. Global Fibromyalgia Treatment Revenue Market Share by Application (2017-2028)
Figure 39. Global Fibromyalgia Treatment Price by Application (2017-2028) & (USD/KG)
Figure 40. North America Fibromyalgia Treatment Sales Market Share by Type (2017-2028)
Figure 41. North America Fibromyalgia Treatment Sales Market Share by Application (2017-2028)
Figure 42. North America Fibromyalgia Treatment Sales Market Share by Country (2017-2028)
Figure 43. North America Fibromyalgia Treatment Revenue Market Share by Country (2017-2028)
Figure 44. United States Fibromyalgia Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Fibromyalgia Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Fibromyalgia Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Fibromyalgia Treatment Sales Market Share by Type (2017-2028)
Figure 48. Europe Fibromyalgia Treatment Sales Market Share by Application (2017-2028)
Figure 49. Europe Fibromyalgia Treatment Sales Market Share by Country (2017-2028)
Figure 50. Europe Fibromyalgia Treatment Revenue Market Share by Country (2017-2028)
Figure 51. Germany Fibromyalgia Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Fibromyalgia Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Fibromyalgia Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Fibromyalgia Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Fibromyalgia Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Fibromyalgia Treatment Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Fibromyalgia Treatment Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Fibromyalgia Treatment Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Fibromyalgia Treatment Revenue Market Share by Region (2017-2028)
Figure 60. China Fibromyalgia Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Fibromyalgia Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Korea Fibromyalgia Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Fibromyalgia Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Fibromyalgia Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Fibromyalgia Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Fibromyalgia Treatment Sales Market Share by Type (2017-2028)
Figure 67. South America Fibromyalgia Treatment Sales Market Share by Application (2017-2028)
Figure 68. South America Fibromyalgia Treatment Sales Market Share by Country (2017-2028)
Figure 69. South America Fibromyalgia Treatment Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Fibromyalgia Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Fibromyalgia Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East & Africa Fibromyalgia Treatment Sales Market Share by Type (2017-2028)
Figure 73. Middle East & Africa Fibromyalgia Treatment Sales Market Share by Application (2017-2028)
Figure 74. Middle East & Africa Fibromyalgia Treatment Sales Market Share by Region (2017-2028)
Figure 75. Middle East & Africa Fibromyalgia Treatment Revenue Market Share by Region (2017-2028)
Figure 76. Turkey Fibromyalgia Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Egypt Fibromyalgia Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Fibromyalgia Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. South Africa Fibromyalgia Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Manufacturing Cost Structure Analysis of Fibromyalgia Treatment in 2021
Figure 81. Manufacturing Process Analysis of Fibromyalgia Treatment
Figure 82. Fibromyalgia Treatment Industrial Chain
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
